News

Earlier on 4 January 2011 the court had ruled in favor of IntelGenx regarding claim construction for the two patent terms at issue in the patent infringement action

AE37 is currently under a randomized and controlled Phase II efficacy study in patients treated for breast cancer who are at high risk of recurrence. Favorable results from

The new health care facility is expected to allow La Red to serve as both a medical – and dental – home for more Sussex County residents. AstraZeneca‘s

Stiefel said PanOxyl Acne Management product line offers different formulations for the treatment and prevention of acne on the face, chest and back. PanOxyl 4% and 8% formulations

The proposed acquisition is expected to allow ALDA to manufacture its own T36 products, to continue the manufacture of SHBP’s own related product lines, which it will retain,

Gemcitabine HCI for Injection, the generic version of Gemcitabine HCI, was launched pursuant to a commercialization, manufacture and supply agreement signed by AstraZeneca and Taj Pharmaceuticals, indiacompanynews.com reported.

The certification was subject to the successful completion of AIFA audit of AMRI’s sterile fill and finish facility in Burlington, MA. This approval specifically applies to laboratories and

The companies will collaborate to advance-to-market an RNAi-based therapy for the treatment of non-muscle invasive bladder cancer. Debiopharm will shoulder full responsibility for the development and commercialization of

MOR103 is implicated in a number of inflammatory and other conditions including rheumatoid arthritis (RA) and multiple sclerosis (MS). The HuCAL-derived, fully human antibody is currently being tested